EMCM B.V.

NovaSterilis Inc. a leader in the development and commercialization of supercritical carbon dioxide (scCO2) technology announces the addition of European Medical Contract Manufacturer (EMCM) as a licensee of supercritical CO2 sterilization and NovaSterilis’ exclusive agent for supercritical CO2 technology and equipment in specified territories.

As part of the PIDON consortium Novio Tissue, EMCM has successfully developed a production process for insoluble highly purified type 1 collagen, derived from bovine tendons. This development further enhances the strategic position of EMCM as a developer and manufacturer of collagen based biomaterials for the healthcare industry.

Stichting Sanquin Bloedvoorziening & EMCM B.V. have entered into a strategic alliance in the area of Tissue Processing, thus offering Dutch hospitals access to clean & sterile hygienically processed bone tissue processed under super critical gas technology (SCC02), in a quest to redefine orthopedic and cranial surgical procedures in the Netherlands.

In the medical and pharmaceutical industry, intricate liquids or powders may be produced and human tissue may be processed by subcontractors whose manufacturing procedures and facilities answer to every stringent requirement. EMCM B.V. manufactures, stores and distributes specialty products such as biomaterials, pharmaceuticals, nutraceuticals, and human tissue constructs. EMCM is headquartered in Nijmegen, the Netherlands.